ClinicalTrials.gov
public full text
Public Domain
Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome
The purpose of this study is to better understand the utility of cannabidiol (CBD/ Epidiolex) for improving the treatment of cognitive impairments in Sturge-Weber syndrome (SWS).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of Cannabidiol (CBD) in Healthy Volunteers#1139759
- Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome#891929
- Cannabidiol Treatment in Patients With Early Psychosis#907182
- The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy#802846
- Effects of Cannabidiol (CBD) on the Brain#898142
Record · ID 870531
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive